From dementia to heart disease: could weight-loss jabs transform chronic conditions?
Science Weekly
00:00
The Cardiovascular Benefits of Weight-Loss Medications
This chapter examines the positive effects of weight-loss medications such as semaglutide, particularly in improving cardiovascular health alongside weight reduction. It discusses recent clinical trial findings that indicate reduced risks of heart attacks and strokes, even in patients who haven’t lost significant weight. Additionally, the chapter explores these drugs' potential impact on chronic conditions like dementia and addiction behaviors, while addressing concerns about their safety and side effects.
Transcript
Play full episode
